![]() |
市场调查报告书
商品编码
1663688
十二指肠内视镜的全球市场 - 市场规模(各市场区隔),占有率,法规,偿付,干预,运作台数,预测(~2036年)Duodenoscopes Market Size by Segments, Share, Regulatory, Reimbursement, Interventions, Installed Base and Forecast to 2036 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
十二指肠镜市场受到多种因素的驱动,其中内视镜逆行胰胆管造影 (ERCP) 干预数量的增加、胃肠道疾病、胆石性胰臟炎患者数量的增加以及急性/慢性胰臟炎是主要推动因素。
本报告提供全球十二指肠内视镜市场相关调查分析,提供各地区市场规模,主要趋势,创新的产品与技术,竞争情形等资讯。
市场模型的主要组成如下:
十二指肠镜市场及不断发展的竞争格局
全球、区域和国家层面的市场洞察
透过获得真正的整体视角(包括医疗保健系统概述)来了解您的市场。此外,市场进入部分提供有关报销政策和监管环境的信息,从而可以更深入地了解市场动态。
对象企业
Duodenoscopes Market Size by Segments, Share, Regulatory, Reimbursement, Interventions, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Endoscopy Devices therapeutic area.
A Duodenoscope is a side viewing endoscope primarily designed for Endoscopic Retrograde Cholangiopancreatography (ERCP) for visualization of the interior of the duodenum. All Duodenoscopes are flexible by design, as these have a flexible insertion tube with video recording facility which uses a charge-coupled device to display magnified images onto a video screen.
Duodenoscopes market is driven by a wide variety of factors, however the market is primarily driven by increase in the number of Endoscopic Retrograde Cholangiopancreatography (ERCP) Interventions, GI disorders, increase in patients with gallstone pancreatitis, and acute and chronic pancreatitis.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes and installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Duodenoscopes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Ambu Inc, Boston Scientific Corp, Olympus Corp, KARL STORZ SE & Co KG, Fujifilm Holdings Corp, PENTAX Medical Co, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -